Literature DB >> 17211816

Leptin and beta2-microglobulin kinetics with three different dialysis modalities.

S Mandolfo1, S Borlandelli, E Imbasciati.   

Abstract

BACKGROUND: Leptin is a protein produced by fat cells and involved in body weight regulation. In patients with normal kidney function, leptin has been considered an independent predictor of cardiovascular events. In uremic patients, leptin in plasma serum was assumed to be associated with malnutrition, inflammation and atherosclerosis. Because of its molecular weight and characteristics, leptin can be considered as a protein-bound uremic retention solute. Some authors have reported the possibility of decreasing the serum leptin concentration with high flux membranes, but limited data are available on the elimination with medium-flux membranes or alternative dialysis strategies such as hemodiafiltration.
METHODS: We evaluated the kinetics of leptin and beta2m in a study of 18 chronic hemodialysis patients using low-flux, medium-flux and high-flux biocompatible membranes, the last one used in hemodiafiltration (HDF). Blood samples for leptin and beta2m were collected pre- and post-treatment and 30 minutes after the end of treatment, over a 1-week period that included 3 dialysis sessions. Clearances of leptin and beta2m across the dialyzer were also determined directly from the arterial and venous blood concentrations 60 and 210 minutes after starting dialysis.
RESULTS: At baseline, all groups showed similar leptin (18.8+/-4.4 ng/mL) and beta2m concentrations (29.2+/-7.1 ng/mL). After a single dialysis session, a reduction of both solutes was observed with HDF (39.8+/-1.9%, 78.1+/-4.9) and medium flux membranes (18.2+/-0.9%, 52.2+/-1.7%), whereas the concentrations remained unchanged with the low-flux membranes. After one-week period, a trend of reduction of plasma pre dialysis leptin and beta2m were observed with HDF and medium flux membranes. At 60 minutes, HDF showed the best instantaneous clearance across the filter for leptin (56.2+/-10.1 ml/min) and beta2m (75.3+/-4.4 ml/min). The magnitude of post dialysis rebound of leptin at 30 min was variable and strongly correlated with the instantaneous clearance of the solute (r2= 0.88).
CONCLUSIONS: Leptin serum concentration can be influenced by dialysis modalities and membrane permeability; data on rebound suggest a multicompartimental kinetic of leptin similar to beta2m. Leptin removal, as measured by the reduction rate, can be considered as an index of dialysis efficiency for protein-bound uremic retention solutes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17211816     DOI: 10.1177/039139880602901005

Source DB:  PubMed          Journal:  Int J Artif Organs        ISSN: 0391-3988            Impact factor:   1.595


  6 in total

1.  Hemodiafiltration to Address Unmet Medical Needs ESKD Patients.

Authors:  Bernard Canaud; Jörg Vienken; Stephen Ash; Richard A Ward
Journal:  Clin J Am Soc Nephrol       Date:  2018-03-06       Impact factor: 8.237

2.  Survival of incident patients on high-volume online hemodiafiltration compared to low-volume online hemodiafiltration and high-flux hemodialysis.

Authors:  Goran Imamović; Rajko Hrvačević; Sonja Kapun; Daniele Marcelli; Inga Bayh; Aileen Grassmann; Laura Scatizzi; Jelena Maslovarić; Bernard Canaud
Journal:  Int Urol Nephrol       Date:  2013-09-21       Impact factor: 2.370

3.  Effect of different dialysis modalities on microinflammatory status and endothelial damage.

Authors:  Ana Merino; José Portolés; Rafael Selgas; Raquel Ojeda; Paula Buendia; Javier Ocaña; M Auxiliadora Bajo; Gloria del Peso; Julia Carracedo; Rafael Ramírez; Alejandro Martín-Malo; Pedro Aljama
Journal:  Clin J Am Soc Nephrol       Date:  2010-01-07       Impact factor: 8.237

4.  Dialyzer Reuse and Outcomes of High Flux Dialysis.

Authors:  Christos Argyropoulos; Maria-Eleni Roumelioti; Abdus Sattar; John A Kellum; Lisa Weissfeld; Mark L Unruh
Journal:  PLoS One       Date:  2015-06-09       Impact factor: 3.240

5.  Curative effect of neutral macroporous resin hemoperfusion on treating hemodialysis patients with refractory uremic pruritus.

Authors:  Wen-Hong Li; Yu-Min Yin; Hao Chen; Xiao-Dan Wang; He Yun; Hui Li; Jie Luo; Jin-Wen Wang
Journal:  Medicine (Baltimore)       Date:  2017-03       Impact factor: 1.889

6.  Randomised, open-label, multicentre trial comparing haemodialysis plus haemoperfusion versus haemodialysis alone in adult patients with end-stage renal disease (HD/HP vs HD): study protocol.

Authors:  Wei Lu; Geng-Ru Jiang
Journal:  BMJ Open       Date:  2018-07-28       Impact factor: 2.692

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.